Skip to main content

NCRR Issues IDeA, High-End Instrumentation Requests

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The National Center for Research Resources has issued its requests for applications for its Institutional Development Award (IDeA) and High-End Instrumentation Grant (HEI) programs for 2012.

The IDeA awards provide funding to enhance biomedical research activities in states that have a historically low rate of receiving National Institutes of Health grants, and the HEI program provides funds for groups of NIH-supported investigators to buy high-cost scientific tools.

Both of these programs next year will be moved from the NCRR, which is being disbanded to make way for the creation of a translational center at NIH, with HEI landing at the Office of the Director, and IDeA moving to the National Institute for General Medical Sciences.

The IDeA grants currently fund projects in 23 states and in Puerto Rico, and next year they will award grants of up to $4 million per year for five years, including an additional one-time cost of $300,000 for alterations and renovations. The total amount it will award for the program next year will depend on NIH's 2012 appropriations.

The HEI program will use $20 million in 2012 to fund purchases of major research items that cost between $750,000 and $2 million each. NCRR said it plans to fund between 10 and 15 new HEI awards.

The IDeA awards are granted through two programs: the Centers of Biomedical Research Excellence (COBRE) and the IDeA Network of Biomedical Research Excellence (INBRE) programs. They are aimed at fostering development of capacity and infrastructure in order to enable IDeA state investigators to become more competitive for traditional NIH grants.

The program's goals include funding studies of the underlying causes of diseases that affect medically underserved populations; development of preventative, diagnostic, and therapeutic measures; integration of basic, clinical, and translational research; and support for mentoring and career development programs.

The HEI awards will fund the purchase of a range of big-ticket tools including, but not limited to, mass spectrometers, supercomputers, biomedical imagers, nuclear magnetic resonance spectrometers, and electron microscopes.

Filed under

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.